Literature DB >> 10897033

Transformation of BALB3T3 cells caused by over-expression of rat CD98 heavy chain (HC) requires its association with light chain: mis-sense mutation in a cysteine residue of CD98HC eliminates its transforming activity.

T Shishido1, S Uno, M Kamohara, T Tsuneoka-Suzuki, Y Hashimoto, T Enomoto, T Masuko.   

Abstract

CD98 is a 125-kDa glycoprotein (GP125) consisting of an 85-kDa heavy chain (HC) and a 40-kDa light chain (LC), and is highly expressed on the cell surface of activated lymphocytes and various tumor cells. In addition to the regulatory role of CD98HC in L-, y(+)L- and Xc-amino-acid transport systems, which are principally mediated by CD98LC, we have reported transforming activity of human CD98HC. In this study, we established and analyzed BALB3T3 clones transfected with cDNAs encoding wild-type and mutated rat CD98HC proteins designated as BrH/Wild, C103S, C325S and 103/325, in which 103 and/or 325 cysteine were intact or replaced with serine. Flow cytometry with anti-rat CD98HC MAb B3 revealed that wild-type and mutated CD98HC transfectants expressed almost the same amounts of rat CD98HC proteins on the cell surface. Immunoprecipitation with B3 revealed that exogenous rat CD98HC proteins were associated with endogenous mouse CD98LC by a disulfide bond in BrH/Wild and C325S, but not in C103S and 103/325 transfectants. These transfectants showed similar doubling times and leucine and arginine transport activities, as compared with BALB3T3 and control transfectants in monolayer culture. Wild-type and C325S transfectants, however, formed much larger anchorage-independent colonies than C103S, 103/325 and control transfectants in soft agar. In addition, wild-type and C325S transfectants showed tumorigenicity in nude mice, although C103S, 103/325 and control transfectants did not. These findings indicate that over-expression of CD98HC and its disulfide-linkage with CD98LC at the cell surface result in malignant transformation of murine fibroblasts. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10897033     DOI: 10.1002/1097-0215(20000801)87:3<311::aid-ijc1>3.0.co;2-w

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction.

Authors:  Soline Estrach; Sin-Ae Lee; Etienne Boulter; Sabrina Pisano; Aurélia Errante; Floriane S Tissot; Laurence Cailleteau; Catherine Pons; Mark H Ginsberg; Chloé C Féral
Journal:  Cancer Res       Date:  2014-09-29       Impact factor: 12.701

2.  Regulation of stem cell function and neuronal differentiation by HERV-K via mTOR pathway.

Authors:  Tongguang Wang; Marie Medynets; Kory R Johnson; Tara T Doucet-O'Hare; Brianna DiSanza; Wenxue Li; Yadi Xu; Anna Bagnell; Richa Tyagi; Kevon Sampson; Nasir Malik; Joseph Steiner; Alina Hadegan; Jeffrey Kowalak; James O'Malley; Dragan Maric; Avindra Nath
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-15       Impact factor: 11.205

Review 3.  Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98.

Authors:  Hang Thi Thu Nguyen; Didier Merlin
Journal:  Cell Mol Life Sci       Date:  2012-03-30       Impact factor: 9.261

Review 4.  CD98 at the crossroads of adaptive immunity and cancer.

Authors:  Joseph M Cantor; Mark H Ginsberg
Journal:  J Cell Sci       Date:  2012-04-12       Impact factor: 5.285

Review 5.  The role of CD98 in astrocytic neoplasms.

Authors:  Hiroshi Nawashiro; Naoki Otani; Nariyoshi Shinomiya; Shinji Fukui; Namiko Nomura; Akiko Yano; Katsuji Shima; Hirotaka Matsuo; Yoshikatsu Kanai
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

Review 6.  Intestinal epithelial CD98: an oligomeric and multifunctional protein.

Authors:  Yutao Yan; Sona Vasudevan; Hang Thi Thu Nguyen; Didier Merlin
Journal:  Biochim Biophys Acta       Date:  2008-06-24

Review 7.  The ancillary proteins of HATs: SLC3 family of amino acid transporters.

Authors:  Manuel Palacín; Yoshikatsu Kanai
Journal:  Pflugers Arch       Date:  2003-05-06       Impact factor: 3.657

8.  L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.

Authors:  Jules Lin; Duna A Raoof; Dafydd G Thomas; Joel K Greenson; Thomas J Giordano; Gregory S Robinson; Maureen J Bourner; Christopher T Bauer; Mark B Orringer; David G Beer
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

9.  Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells.

Authors:  Kazue Masuko; Shogo Okazaki; Mayumi Satoh; Goh Tanaka; Tatsuya Ikeda; Ryota Torii; Eri Ueda; Takashi Nakano; Masaaki Danbayashi; Tomoyo Tsuruoka; Yoshiya Ohno; Hideki Yagi; Noritsugu Yabe; Hideaki Yoshida; Tomoyuki Tahara; Shiro Kataoka; Taichi Oshino; Takayuki Shindo; Shin-ichiro Niwa; Takatsugu Ishimoto; Hideo Baba; Yoshiyuki Hashimoto; Hideyuki Saya; Takashi Masuko
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

10.  Beta1 integrins show specific association with CD98 protein in low density membranes.

Authors:  T V Kolesnikova; B A Mannion; F Berditchevski; M E Hemler
Journal:  BMC Biochem       Date:  2001-10-15       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.